Haruko Obokata, 30, was feted after unveiling research that appeared to show a straightforward way to re-programme adult cells to become a kind of stem cell.
Stem cells are precursors that are capable of developing into any other cell in the human body, and a readily manufacturable supply of them could one day help meet a need for transplant tissues, or even whole organs.
But within weeks of her paper on so-called Stimulus-Triggered Acquisition of Pluripotency (STAP) cells being published, questions began to emerge, with fellow scientists saying they could not replicate her results.
Obokata has agreed with her co-authors to a partial retraction, saying: "I don't oppose withdrawing one of the" papers, according to the Yomiuri Shimbun, Kyodo News and other media.
But her lawyer said that she won't withdraw the main paper, and insists she successfully created STAP cells on several occasions.
The paper to be withdrawn noted the versatility of the cells, while the other paper summed up the cells' characteristics and method of making them.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
